Sunshine Heart, which is developing technology to treat heart failure, has raised $14 million through a public offering. The company plans to put the capital toward clinical trials, product development and other corporate purposes. Sunshine (NASDAQ: SSH) was founded in Australia and established its U.S. headquarters in Eden Prairie three years ago.
